Literature DB >> 14071629

METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.

R G LUKE, A C KENNEDY.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; HYPERTENSION, RENAL; KIDNEY FUNCTION TESTS; METHYLDOPA

Mesh:

Substances:

Year:  1964        PMID: 14071629      PMCID: PMC1813017     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

2.  Methyldopa in the treatment of hypertension.

Authors:  R I BAYLISS; E A HARVEY-SMITH
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

3.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

4.  Another hypotensive agent--methyldopa.

Authors:  D DALEY; B EVANS
Journal:  Br Med J       Date:  1962-07-21

5.  Renal factors in the production of hypertension.

Authors:  C WILSON
Journal:  Lancet       Date:  1953-09-26       Impact factor: 79.321

6.  Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension.

Authors:  G ONESTI; A N BREST; P NOVACK; J H MOYER
Journal:  Am J Cardiol       Date:  1962-06       Impact factor: 2.778

7.  Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response.

Authors:  J H MOYER; C A HANDLEY; R A HUGGINS
Journal:  J Pharmacol Exp Ther       Date:  1951-12       Impact factor: 4.030

8.  Endogenous creatinine in serum and urine.

Authors:  R S HARE
Journal:  Proc Soc Exp Biol Med       Date:  1950-05
  8 in total
  4 in total

1.  Recent concepts in the clinical pharmacology of anithypertensive drugs.

Authors:  A S Nies; K L Melmon
Journal:  Calif Med       Date:  1967-05

2.  Effect of -methyldopa on renal plasma flow in patients with renal hypertension.

Authors:  G Majdrakov; G Mitrov; D Mushmov; L Salambashev; G Todorov
Journal:  Int Urol Nephrol       Date:  1971       Impact factor: 2.370

3.  Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).

Authors:  V Vejlsgaard; M Christensen; E Clausen
Journal:  Br Med J       Date:  1967-06-03

4.  The long-term effectiveness of methyldopa in hypertension.

Authors:  R Okun; S E Roth; A Gordon; M H Maxwell
Journal:  Calif Med       Date:  1966-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.